Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Report Description
Antibiotics are used in livestock production to treat diseases in animals, to control infection of disease among healthy animals, to prevent disease in animals, and to increase animal productivity. Antibiotics keep poultry and livestock healthy, thereby reducing the chance of bacterial transmission from animals to humans. Majority of antibiotics drugs approved for use in food-producing animals through their feed or water are available over-the-counter.
Market Dynamics
Increasing demand for animal protein and growing demand for food production from animal source is leading driver for use of antibiotics in animal agriculture. Several countries across the world produce meat and aquaculture products. According to Organization for Economic Co-Operation and Development (OECD), an average U.S. adult consumed 198 pounds of meat in 2014. According to the WHO 2015 report, South East Asia region (SEAR) has developed intensive farming systems, leading to the rising consumption of fertilisers, antibiotics, and pesticides.
However, over-use and misuse of antibiotics in animals and humans is rising threat of antibiotic resistance. Therefore, governments across the globe are banning or limiting use of antibiotics in animal production and growth. For instance, in November 2018, European Union (EU) approved restrictions on Veterinary Antibiotics. The new legislation, which is expected to become law by 2022, bans use of antibiotics for animals, which are important for human medicine and prohibits use of any antimicrobials in livestock without a prescription from a veterinary doctor. In 2016, the United Nations General Assembly (UNGA) brought together the global community in declaring antimicrobial resistance (AMR) as a major concern and a global commitment to fight an issue through multi-pronged approaches.
Key features of the study:
• This report provides in-depth analysis of the veterinary antibiotics market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2019 - 2026, considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global veterinary antibiotics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale, Crystal Pharma, Dechra Pharmaceuticals PLC, Huvepharma AD, Eli Lilly Company, Elanco, Merck & Co., Inc., Sanofi, Vetoquinol S.A., Virbac, and Zoetis, Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global veterinary antibiotics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for veterinary antibiotics market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
• Global Veterinary Antibiotics Market, By Product Type:
o Anti-parasitic
o Anti-bacterial
o Non-steroidal anti-inflammatory drug
o Others
• Global Veterinary Antibiotics Market, By End Use:
o Dairy Farm
o Poultry Farm
o Others
• Global Veterinary Antibiotics Market, By Region:
o North America
o By Country:
o U.S.
o Canada
o By Product Type:
o Anti-parasitic
o Anti-bacterial
o Non-steroidal anti-inflammatory drug
o Others
o By End Use:
o Dairy Farm
o Poultry Farm
o Others
o Europe
o By Country:
o U.K.
o Germany
o Italy
o Spain
o France
o Russia
o Rest of Europe
o By Product Type:
o Anti-parasitic
o Anti-bacterial
o Non-steroidal anti-inflammatory drug
o Others
o By End Use:
o Dairy Farm
o Poultry Farm
o Others
o Asia Pacific
o By Country:
o Australia
o India
o China
o Japan
o ASEAN
o South Korea
o Rest of Asia Pacific
o By Product Type:
o Anti-parasitic
o Anti-bacterial
o Non-steroidal anti-inflammatory drug
o Others
o By End Use:
o Dairy Farm
o Poultry Farm
o Others
o Latin America
o By Country:
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o By Product Type:
o Anti-parasitic
o Anti-bacterial
o Non-steroidal anti-inflammatory drug
o Others
o By End Use:
o Dairy Farm
o Poultry Farm
o Others
o Middle East
o By Country:
o GCC
o Israel
o Rest of Middle East
o By Product Type:
o Anti-parasitic
o Anti-bacterial
o Non-steroidal anti-inflammatory drug
o Others
o By End Use:
o Dairy Farm
o Poultry Farm
o Others
o Africa
o By Country:
o South Africa
o Central Africa
o North Africa
o By Product Type:
o Anti-parasitic
o Anti-bacterial
o Non-steroidal anti-inflammatory drug
o Others
o By End Use:
o Dairy Farm
o Poultry Farm
o Others
• Company Profiles
o Bayer AG*
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Boehringer Ingelheim GmbH
o Ceva Sante Animale S.A.
o Crystal Pharma
o Dechra Pharmaceuticals PLC
o Huvepharma AD
o Eli Lilly Company
o Merck & Co., Inc.
o Sanofi S.A.
o Vetoquinol S.A.
o Virbac
o Zoetis, Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Product Type
o Market Snippet, By End Use
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Regulatory Landscape
o Antibiotics Substitutes
o Epidemiology Analysis
o PEST Analysis
4. Global Veterinary Antibiotics Market, By Product Type, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Anti-parasitic
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Anti-bacterial
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Non-steroidal anti-inflammatory drug
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Veterinary Antibiotics Market, By End Use, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Dairy Farm
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Poultry Farm
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Veterinary Antibiotics Market, By Region, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End Use, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End Use, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End Use, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End Use, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End Use, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Product Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End Use, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Bayer AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Boehringer Ingelheim GmbH
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Ceva Sante Animale S.A.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Crystal Pharma
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Dechra Pharmaceuticals PLC
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Huvepharma AD
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Eli Lilly Company
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Elanco
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Merck & Co., Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Sanofi S.A.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Vetoquinol S.A.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Virbac
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Zoetis, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
8. Section
o Analyst Views
o References
o Research Methodology
o About Us and Sales Contact
*Browse 23 market data tables and 18 figures on "Veterinary Antibiotics Market" - Global forecast to 2026".
